Homechevron_rightAll Peptideschevron_rightBPC-157

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-bpc-157-5mg

Official Product Data Sheet

BPC-157 (5mg)

Ultra High >99.8% Purity

Vial Contents

5 mg BPC-157 (lyophilized powder)

Includes

3 ml bacteriostatic water for reconstitution

Form

Lyophilized white powder for optimal stability

Purity

≥99%, third-party tested (COA available)

Sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula

C₆₂H₉₈N₁₆O₂₂

Molecular Mass

1419.5 g/mol

CAS No.

137525-51-0

Solubility

Reconstitute with sterile/bacteriostatic water (3 ml for ~1.67 mg/mL)

Storage

Lyophilized frozen at −20°C; reconstituted refrigerated at 2–8°C for up to 4 weeks

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Europe

local_shipping1-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Retatrutridekopen.com

Europe

local_shipping3-5 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

Scientific Background

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective protein found in gastric juice, studied for its tissue-healing and cell-protecting properties.

Preclinical models show it speeds up wound repair and reduces inflammation, while human data is limited to early safety trials and small case reports. As an investigational compound, BPC-157 is not approved for therapeutic use and is provided strictly for research purposes into healing, regeneration, and cytoprotection.

Research protocols usually involve once-daily subcutaneous delivery, with dosing based on animal models showing regenerative benefits. Preclinical evidence points to support for molecular repair and renewal under stress, affecting blood vessel and cell-protective signals.

Intended Research Use

Tissue repair in gut, tendon, muscle, and skin injury models
Anti-inflammatory and cytoprotective properties research
Molecular repair and regenerative processes under stress conditions
Nitric oxide pathway and growth factor modulation studies
Blood vessel formation and collagen buildup in damaged tissues

menu_bookScientific Publications

article

J Pharmacol Sci (2008)

Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease, is effective in the healing of colocutaneous fistulas in rats

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/18827458/

article

Pharmaceuticals (2025)

Multifunctionality and Possible Medical Application of BPC-157: Literature and Patent Review

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/38156225/

article

Curr Pharm Des (2018)

Stable Gastric Pentadecapeptide BPC 157-NO-Release and Clopidogrel, the New Double Jeopardy Demonstrated by Capillaries Failure

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29714139/

article

Curr Pharm Des (2018)

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29345512/

article

HSS J (2025)

The Emerging Use of Peptide Therapeutics in Orthopaedic Sports Medicine: A Scoping Review

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/38314295/

article

J Appl Physiol (2011)

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/21030672/

article

Curr Med Chem (2011)

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/21083588/

article

Curr Pharm Des (2018)

BPC 157 as Potential Agent Rescuing from Cancer Cachexia

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29714140/

Research Note: BPC-157 influences blood vessel and cell-protective signaling through nitric oxide pathways, growth factor expression, and matrix remodeling. Preclinical studies suggest it promotes blood vessel formation and collagen buildup in damaged tissues with high tolerance in early research.

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Preclinical research suggests combining BPC-157 with complementary peptides can enhance tissue repair and regeneration outcomes. These combinations are frequently examined in injury recovery, wound healing, and regenerative medicine research, where multiple pathway targeting may yield amplified effects on tissue building and repair.

TB-500

arrow_forward

myo-tb-500-5mg

For synergistic tissue repair and regeneration — the classic combo for accelerated injury healing.

GHK-Cu

arrow_forward

myo-ghk-cu-50mg

For enhanced wound healing and skin/tissue recovery with collagen production support.

IGF-1 LR3

arrow_forward

myo-igf-1-lr3-1mg

For muscle and tissue growth support through complementary growth signaling.

Thymosin Alpha-1

arrow_forward

myo-thymosin-alpha-1-10mg

For immune modulation during recovery and enhanced healing response.

schedule

Cycling Note: Standard research cycles are 8–12 weeks with optional extension to 16 weeks. Consider rest periods between cycles to maintain responsiveness.